Post-COVID-19 Respiratory Management: Expert Panel Report

Guleria, Randeep; Solanki, Rajesh; Goel, Nitin; Menon, Balakrishnan; Chetambath, Ravindran; Madan, Karan; Behera, Digambar; Mishra, Narayan Chandra; Kumar, Deependra; Dhooria, Sahajal; Talwar, Deepak; Thangakunam, Balamugesh; Nath, Alok; Spalgais, Sonam; Koul, Parvaiz A; Gupta, Nitesh; Sindhwani, Girish; Kumar, Raj; Mrigpuri, Parul; Mohapatra, Prasanta Raghab; Janmeja, Ashok Kumar; Bansal, Vishal; Jindal, Surinder K.; Ghoshal, Alok Gopal; Hazarika, Basanta; Chaudhary, Dhruv; D\'Souza, George A.; Sen, M. K.; Bhargava, S.

doi:10.5005/ijcdas-62-4-179

Cited by 4 publications

(1 citation statement)

References 24 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Therefore, it is universally recommended to closely follow COVID-19-infected patients in the post-COVID period, for persistent or new symptoms. 9 , 10 In the present study, we analyzed the clinical, laboratory, and radiological parameters of 150 long-COVID patients who presented to us with persistent or newly developed respiratory symptoms. Simultaneously, we studied the clinicoradiological findings in long-COVID patients in relation to the severity of their acute COVID-19 illness.…”

Section: Introductionmentioning

confidence: 99%

Initial COVID-19 Severity and Long-COVID Manifestations: An Observational Analysis

Goel¹,

Goyal²,

Spalgais³

et al. 2023

Thorac Res Pract

View full text Add to dashboard Cite

OBJECTIVE: New-onset or persistent symptoms beyond after 4 weeks from COVID-19 are termed “long-COVID.” Whether the initial severity of COVID-19 has a bearing on the clinicoradiological manifestations of long COVID is an area of interest. MATERIAL AND METHODS: We did an observational analysis of the long-COVID patients after categorizing them based on their course of COVID-19 illness into mild, moderate, and severe groups. The clinical and radiological profile was compared across these groups. RESULTS: Out of 150 long-COVID patients recruited in the study, about 79% (118), 14% (22), and 7% (10) had a history of mild, moderate, and severe COVID-19, respectively. Fatigue ( P = .001), breathlessness ( P = .001), tachycardia ( P = .002), tachypnea ( P < .001), raised blood pressure ( P < .001), crepitations ( P = .04), hypoxia at rest ( P < .001), significant desaturation in 6-minute walk test ( P = .27), type 1 respiratory failure ( P = .001), and type 2 respiratory failure ( P = .001) were found to be significantly higher in the long-COVID patients with a history of severe COVID-19. These patients also had the highest prevalence of abnormal chest X-ray (60%) and honeycombing in computed tomography scan thorax (25%, P = .027). CONCLUSION: The course of long COVID bears a relationship with initial COVID-19 severity. Patients with severe COVID-19 are prone to develop more serious long-COVID manifestations.

show abstract

Section: Introductionmentioning

confidence: 99%

Initial COVID-19 Severity and Long-COVID Manifestations: An Observational Analysis

Goel¹,

Goyal²,

Spalgais³

et al. 2023

Thorac Res Pract

View full text Add to dashboard Cite

show abstract

Addressing Post-COVID Fibrosis and Illness: A Call to Action

Mohapatra¹

2022

The Indian Journal of Chest Diseases and Allied Sciences

Self Cite

View full text Add to dashboard Cite

The ongoing pandemic COVID-19 has created unprecedented challenges for mankind across the world. This global crisis has prompted a change in priority of the health system reorganisation. Although mortality is not beyond control, morbidity and post-COVID illness in absolute numbers are excessive. Hence, to address this grim situation is highly important and worth focusing at this stage, since the number of patients with post-COVID disability continue to rise despite the decline in the overall cases of the pandemic.

show abstract

Post-COVID Pulmonary Sequelae: The Management Strategy

Kumar¹

2022

The Indian Journal of Chest Diseases and Allied Sciences

Self Cite

View full text Add to dashboard Cite

COVID-19 pandemic has placed a huge burden on health authorities worldwide. The epidemiology, clinical characteristics, management and complication of acute phase of COVID-19 has been well described. 1,2 However, the data for its long-term complications and management remain still unclear. Post-COVID patients may continue to report variety of signs and symptoms which may range from milder ones to serious organ specific manifestations. 3,4 Recently, some management strategies for Long COVID-19 has been formulated by Goel and co-authors, published in this issue of the journal. 5The terms like 'Post-COVID syndrome', Long Haul COVID' and 'Post-COVID Sequelae' have been used in the literature for such persistent signs and symptoms. 6 NICE (National Institute for Health and Care Excellence) describe Acute COVID, Ongoing COVID and Post-COVID having symptoms ≤4 weeks, 4-12 weeks, >12 weeks, respectively. It has coined the term 'Long-COVID' for symptoms persistent beyond four weeks from acute COVID-19 infection. 7,8 In most of the studies 8-12 , the most common observed post-COVID symptom are fatigue and weakness (63%), dyspnoea (26%), sleeping difficulty (26%), anxiety and depression (23%), hoarseness (22%), smell disorder (11%), palpitation (9%), joint pain (9%), etc. Post-COVID symptoms mostly depends on the severity of the infection during acute phase, patients who were more severely ill during their hospital stay had more sever impaired pulmonary diffusion capacity and abnormal chest imaging manifestations. 10,11 In another study 13 , at 8-12 weeks post admission, 74% persisted with symptoms (notably breathlessness and excessive fatigue) with reduced health related quality-of-life (HRQoL). Further 59%, 75%, 89% at least one symptom persisted in mild COVID (without oxygen), moderate COVID (with oxygen), and severe COVID (NIV [noninvasive ventilation]) at 8-12 weeks, respectively. The study demonstrate the persistence of symptom at 12 weeks in majority of patients even those with mild disease initially.

show abstract

Post-COVID-19 Respiratory Management: Expert Panel Report

Cited by 4 publications

References 24 publications

Initial COVID-19 Severity and Long-COVID Manifestations: An Observational Analysis

Initial COVID-19 Severity and Long-COVID Manifestations: An Observational Analysis

Addressing Post-COVID Fibrosis and Illness: A Call to Action

Post-COVID Pulmonary Sequelae: The Management Strategy

Contact Info

Product

Resources

About